Results of Mitral Valve Repair in Rheumatic Mitral Lesions
DOI:
https://doi.org/10.1532/HSF98.20091109Abstract
Background: We compared results for repairs of rheumatic pure mitral regurgitation (MR) and mixed mitral stenosis (MS) and MR during early and midterm time intervals.
Methods: We retrospectively analyzed 173 patients (mean age 47.6 ± 15.1 years; 64 males) who underwent surgery for rheumatic heart disease during the period from January 1998 to June 2008. According to transvalvular mitral gradient, 91 patients had pure MR (group MR) and 82 (47%) had mixed MS-MR (group MS/MR). Preoperative and operative characteristics, postoperative MR severity, operative mortality, and early and midterm survival were examined for each surgical group.
Results: Preoperativley 153 patients (90.7%) were in New York Heart Association class III or IV. The most frequent pathology was leaflet prolapse (147 patients, 85.0%) and the most commonly performed procedure was annuloplasty (162 patients, 93.6%). Early mortality was similar for both groups (3.2% versus 1.2%; P = .621). The average duration of follow-up was 4.0 ± 2.4 years (a total of 679.1 patient years). Logistic regression analysis results indicated that subvalvular repairs were related to mortality. There were no significant differences in early mortality rate, valve-related morbidity, or reoperations.
Conclusion: Group MS/MR had more postoperative MR severity, and higher New York Heart Association class, but both groups had similar mortality and morbidity at the midterm survival point. Our results suggest that combined MS and MR repair can be performed as safely as pure MR.
References
Adams DH, Anyanwu AC. 2006. Pitfalls and limitations in measuring and interpreting the outcomes of mitral valve repair. J Thorac Cardiovasc Surg 131:523-9.nAkins CW, Miller DC, Turina MI, et al. 2008. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 135:732-8.nBernal JM, Fernández-Vals M, Rabasa JM, Gutiérrez-García F, Morales C, Revuelta JM. 1998. Repair of nonsevere rheumatic aortic valve disease during other procedures: is it safe? J Thoracic Cardiovasc Surg 115:1130-5.nBonow RO, Carabello BA, Kanu C, et al. 2006. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84-231.nBozbuga N, Isik Ö, Akinci E, Yakut C. 1997. The database formation and statistical modelling for valvular operations at Kosuyolu Heart and Research Hospital. Kosuyolu Heart J 2:156-64.nBozbuga N, Guler M, Kirali K, Akinci E, Isik O, Yakut C. 2003. Durability of valve reconstruction in rheumatic mitral and aortic valves: controversies in the best treatment for double valve disease. Cardiovascular Forum Online 0037-46.nChoudhary SK, Talwar S, Dubey B, Chopra A, Saxena A, Kumar AS. 2001. Mitral valve repair in a predominantly rheumatic population. Long-term results. Tex Heart Inst J 28:8-15.nDuran CM, Gometza B, De Vol EB. 1991. Valve repair in rheumatic mitral disease. Circulation 84(5 Suppl):III125-32.nErez E, Kanter KR, Isom E, Williams WH, Tam VK. 2003. Mitral valve replacement in children. J Heart Valve Dis 12:25-9.nFedak PW, McCarthy PM, Bonow RO. 2008. Evolving concepts and technologies in mitral valve repair. Circulation 117;963-74.nKumar AS, Rao PN, Saxena A. 1995. Results of mitral valve reconstruction in children with rheumatic heart disease. Ann Thorac Surg 60:1044-7.nKumar AS, Talwar S, Saxena A, Singh R, Velayoudam D. 2006. Results of mitral valve repair in rheumatic mitral regurgitation. Interact Cardiovasc Thorac Surg 5:356-61.n
